Advanced search
Publication Cover
Patient Preference and Adherence Volume 12, 2018 - Issue
Submit an article Journal homepage
55
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Factors influencing the use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice

Peter C Taylor1 Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK, [email protected]Correspondence[email protected]
,
Rieke Alten2 Department of Internal Medicine II, Rheumatology, Clinical Immunology, and Osteology, Schlosspark Klinik, University Medicine Berlin, Berlin, Germany
,
Juan J Gomez Reino3 Experimental and Observational Rheumatology and Rheumatology Unit, Fundacion Ramon Dominguez and Rheumatology, Hospital Clinico Universitario, Santiago de Compostela, Spain
,
Roberto Caporali4 Division of Rheumatology, IRCCS Foundation Policlinico S. Matteo, University of Pavia, Pavia, Italy
,
Philippe Bertin5 Service de Rhumatologie, CHU Dupuytren, Limoges, France
,
Emma Sullivan6 Real-World Evidence and Epidemiology, Adelphi Real World, Bollington, UK
,
Robert Wood6 Real-World Evidence and Epidemiology, Adelphi Real World, Bollington, UK
,
James Piercy6 Real-World Evidence and Epidemiology, Adelphi Real World, Bollington, UK
,
Radu Vasilescu7 Medical Affairs, International Developed Markets, Pfizer, Brussels, Belgium
,
Dean Spurden8 Health Economics and Outcomes Research, Pfizer Ltd, Tadworth, UK
,
Jose Alvir9 Statistical Research and Data Science Center, Global Product Development, Pfizer Inc, New York, NY, USA
&
Miriam Tarallo10 Patient and Health Impact, Pfizer Italia Srl, Rome, Italy
 show all
Pages 2007-2014 | Published online: 04 Oct 2018

References

  • SmolenJSAletahaDMcinnesIBRheumatoid arthritisLancet2016388100552023203827156434
  • SinghJASaagKGBridgesSL2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisArthritis Care Res2016681125
  • SmolenJSLandewéRBijlsmaJEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateAnn Rheum Dis201776696097728264816
  • EspinozaFFabreSPersYMRemission-induction therapies for early rheumatoid arthritis: evidence to date and clinical implicationsTher Adv Musculoskelet Dis20168410711827493689
  • MontiSMontecuccoCBugattiSCaporaliRRheumatoid arthritis treatment: the earlier the better to prevent joint damageRMD Open20151Suppl 1e00005726557378
  • SmolenJSBreedveldFCBurmesterGRTreating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceAnn Rheum Dis201675131525969430
  • SmolenJSTreat-to-target as an approach in inflammatory arthritisCurr Opin Rheumatol201628329730227027815
  • SmolenJSTreat-to-target: rationale and strategiesClin Exp Rheumatol2012304 Suppl 73S2S623073266
  • RidkerPMMoving toward new statin guidelines in a post-JUPITER world: principles to considerCurr Atheroscler Rep200911424925619500487
  • Diabetes Control and Complications Trial Research GroupEffect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research GroupJ Pediatr199412521771888040759
  • GrigorCCapellHStirlingAEffect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trialLancet2004364943026326915262104
  • KnevelRSchoelsMHuizingaTWCurrent evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritisAnn Rheum Dis201069698799420448280
  • BakkerMFJacobsJWWelsingPMLow-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trialAnn Intern Med2012156532933922393128
  • TugnetNPearceFTosounidouSTo what extent is NICE guidance on the management of rheumatoid arthritis in adults being implemented in clinical practice? A regional surveyClin Med20131314246
  • European Pharmaceutical Market Research Association (EphMRA) [webpage on the Internet]Code of Conduct2017 Available from: http://www.ephmra.org/Code-of-Conduct-SupportAccessed June 28, 2017
  • GottliebAKormanNJGordonKBGuidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologicsJ Am Acad Dermatol200858585186418423261
  • GreenappleRTrends in biologic therapies for rheumatoid arthritis: results from a survey of payers and providersAm Health Drug Benefits201252839224991313
  • LloydSBujkiewiczSWailooAJSuttonAJScottDThe effectiveness of anti-TNF-alpha therapies when used sequentially in rheumatoid arthritis patients: a systematic review and meta-analysisRheumatology201049122313232120566736
  • Rendas-BaumRWallensteinGVKonczTEvaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitorsArthritis Res Ther2011131R2521324169
  • SmolenJSBurmesterGRCombeBHead-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE studyLancet2016388100612763277427863807
  • CaporaliRContiFCovelliMTreating rheumatoid arthritis to target: an Italian rheumatologists’ survey on the acceptance of the treat-to-target recommendationsClin Exp Rheumatol201432447147624960620
  • HaraouiBBensenWBessetteLLe ClercqSThorneCWadeJTreating rheumatoid arthritis to target: a Canadian physician surveyJ Rheumatol201239594995322467920
  • HetlandMLJensenDVKroghNSMonitoring patients with rheumatoid arthritis in routine care: experiences from a treat-to-target strategy using the DANBIO registryClin Exp Rheumatol2014325 Suppl 85S141S14624528956
  • SmolenJSLandewéRBreedveldFCEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateAnn Rheum Dis201473349250924161836
  • TaylorPCAltenRGomez-ReinoJJClinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatmentRMD Open201841e00061529593881

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.